Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    12506176 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus Cisplatin
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: docetaxel - cisplatin - 5-fluorouracil;   Radiation: radiotherapy;   Drug: cetuximab;   Drug: cisplatin
2 Completed Cabazitaxel - PF Induction Chemotherapy
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Cabazitaxel 10mg/m2;   Drug: Cabazitaxel 12.5mg/m2;   Drug: Cabazitaxel 15mg/m2;   Drug: Cabazitaxel 17.5mg/m2;   Drug: Cabazitaxel 20mg/m2
3 Recruiting Quarterback 2 - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer
Condition: Locally Advanced HPV Positive Oropharynx Cancer
Interventions: Radiation: PTV56;   Radiation: PTV50.4
4 Recruiting The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer
Condition: Squamous Cell Carcinomas
Interventions: Radiation: Reduced Dose Radiation;   Radiation: Standard Dose Radiation

Study has passed its completion date and status has not been verified in more than two years.